As of January 22, 2025, Passage Bio (PASG) has a market cap of $36.807 million USD. According to our data, Passage Bio is ranked No.8330 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $36.81 M |
5.10%
|
Dec 31, 2024 | $35.02 M |
-43.86%
|
Dec 29, 2023 | $62.38 M |
-26.81%
|
Dec 30, 2022 | $85.24 M |
-78.27%
|
Dec 31, 2021 | $0.39 B |
-75.17%
|
Dec 31, 2020 | $1.58 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Adverum Biotechnologies
ADVM
|
$92.99 M |
-0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
MeiraGTx
MGTX
|
$0.47 B |
-0.000 M
|
USA
|
Solid Biosciences
SLDB
|
$0.12 B |
-0.000 M
|
USA
|
Generation Bio
GBIO
|
$63.83 M |
-0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Market Cap | = | PASG Stock Price | * | PASG Shares Outstanding |
= | $0.60 | * | 61.77 M | |
= | $36.81 M |